Company Filing History:
5 out of 21 
3 out of 120 
2 out of 174 Years Active: 2001-2009
Title: Terence J Moran: A Pioneer in Quinobenzoxazine Innovation
Introduction
Terence J Moran is a distinguished inventor based in San Diego, California, renowned for his contributions to the field of pharmaceuticals through his extensive work on quinobenzoxazine compounds. With a remarkable portfolio that includes 12 patents, he has positioned himself as a notable figure in medicinal chemistry, focusing on innovative solutions for complex health challenges.
Latest Patents
Among Terence's latest innovations are patents related to substituted quinobenzoxazine analogs. These compounds are described by the general formula combining various substituents (A, U, V, W, X, and Z) and include pharmaceutically acceptable salts, esters, and prodrugs. His work not only elucidates the chemical properties and synthesis of these analogs but also outlines methods for their application, specifically in processes such as screening and inducing apoptosis. Such innovations hold potential therapeutic value, making significant strides in the pharmaceutical industry.
Career Highlights
Over his career, Terence has made substantial contributions while working with leading biotechnology companies, including Cylene Pharmaceuticals, Inc. and Neurocrine Biosciences, Inc. His experience in these organizations has afforded him the opportunity to integrate his inventive ideas into practical applications, driving forward the development of novel therapies.
Collaborations
Collaboration plays a crucial role in the advancement of innovation, and Terence has worked alongside esteemed colleagues, including Jeffrey Paul Whitten and Michael Schwaebe. Together, they have pursued groundbreaking research, further amplifying the impact of their findings within the scientific community.
Conclusion
In conclusion, Terence J Moran's dedication to innovation in the realm of quinobenzoxazine compounds exemplifies the essential intersection of creativity and technology in pharmaceuticals. His extensive patent portfolio and collaboration with industry professionals highlight his position as a significant inventor, contributing to ongoing advancements that may benefit healthcare outcomes in the future.